Reuters Health News Summary | Health
India's Manipal Health Enterprises' $960.4 million IPO was oversubscribed, led by institutional investors, while Glenmark Pharmaceuticals posted a 53.6% jump in quarterly profit due to strong demand for its drugs.
Following is a summary of current health news briefs. India's Manipal Health IPO oversubscribed as institutional demand outweighs retail caution Manipal Health Enterprises' $960.4 million initial p… [+6171 chars]